T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan Inc
AGN
|
+$1.3B |
| 2 |
American Airlines Group
AAL
|
+$853M |
| 3 |
Intuitive Surgical
ISRG
|
+$816M |
| 4 |
Morgan Stanley
MS
|
+$681M |
| 5 |
Wynn Resorts
WYNN
|
+$622M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Procter & Gamble
PG
|
+$1.4B |
| 2 |
eBay
EBAY
|
+$763M |
| 3 |
DISCK
Discovery, Inc. Series C Common Stock
DISCK
|
+$760M |
| 4 |
Broadcom
AVGO
|
+$757M |
| 5 |
US Bancorp
USB
|
+$686M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 16.64% |
| 2 | Consumer Discretionary | 13.46% |
| 3 | Financials | 12.79% |
| 4 | Industrials | 12.13% |
| 5 | Technology | 9.46% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
CMRX
851
DELISTED
Chimerix, Inc.
CMRX
| $52.7M | 0.01% |
2,402,280
+1,174,719
| +96% | +$23.3M |
|
852
Palo Alto Networks
PANW
$323B
| $52.6M | 0.01% |
3,760,482
-1,013,250
| -21% | -$11.8M |
|
|
TFM
853
DELISTED
THE FRESH MARKET, INC COM STK
TFM
| $52.4M | 0.01% |
1,566,007
-2,980
| -0.2% | -$101K |
|
|
WMGI
854
DELISTED
Wright Medical Group Inc
WMGI
| $52.3M | 0.01% |
1,666,286
-7,058
| -0.4% | -$211K |
|
|
LO
855
DELISTED
LORILLARD INC COM STK
LO
| $52.2M | 0.01% |
855,925
-1,581,291
| -65% | -$92M |
|
856
Hasbro
HAS
$13.6B
| $51.9M | 0.01% |
977,912
-83,500
| -8% | -$4.51M |
|
857
Quanex
NX
$981M
| $51.8M | 0.01% |
2,898,370
-216,880
| -7% | -$4.06M |
|
858
Columbia Banking Systems
COLB
$9.18B
| $51.7M | 0.01% |
1,964,500
+92,170
| +5% | +$2.4M |
|
|
SSI
859
DELISTED
Stage Stores Inc
SSI
| $51.7M | 0.01% |
2,764,810
-19,940
| -0.7% | -$399K |
|
|
ATW
860
DELISTED
Atwood Oceanics
ATW
| $51.5M | 0.01% |
981,480
+10,900
| +1% | +$537K |
|
861
Zions Bancorporation
ZION
$10.5B
| $51.3M | 0.01% |
1,739,881
+64,000
| +4% | +$1.88M |
|
862
Chesapeake Utilities
CPK
$3.26B
| $51M | 0.01% |
1,071,806
-10,950
| -1% | -$475K |
|
|
WAGE
863
DELISTED
WageWorks, Inc.
WAGE
| $50.9M | 0.01% |
1,055,900
+1,045,400
| +9,956% | +$46.6M |
|
|
SAND
864
DELISTED
Sandstorm Gold
SAND
| $50.9M | 0.01% |
7,326,270
+1,810,900
| +33% | +$10.5M |
|
|
EXPR
865
DELISTED
Express, Inc.
EXPR
| $50.8M | 0.01% |
149,181
-796
| -0.5% | -$238K |
|
|
ISEE
866
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
| $50.5M | 0.01% |
1,192,547
+196,724
| +20% | +$7.22M |
|
867
Sonida Senior Living
SNDA
$1.88B
| $50.2M | 0.01% |
140,405
+726
| +0.5% | +$263K |
|
868
RLI Corp
RLI
$5.87B
| $50M | 0.01% |
2,184,960
-30,960
| -1% | -$684K |
|
|
RLD
869
DELISTED
REALD INC COM STK
RLD
| $50M | 0.01% |
3,918,100
-518,400
| -12% | -$6.01M |
|
|
JNS
870
DELISTED
Janus Capital Group Inc
JNS
| $50M | 0.01% |
4,003,585
+3,914,385
| +4,388% | +$46.1M |
|
|
ULTI
871
DELISTED
Ultimate Software Group Inc
ULTI
| $49.8M | 0.01% |
360,287
+216,687
| +151% | +$27.6M |
|
|
INVN
872
DELISTED
Invensense Inc
INVN
| $49.7M | 0.01% |
2,189,560
+1,385,140
| +172% | +$28.3M |
|
873
Devon Energy
DVN
$48.8B
| $49.3M | 0.01% |
621,174
-4,820
| -0.8% | -$351K |
|
874
Cohen & Steers
CNS
$4.4B
| $48.9M | 0.01% |
1,126,390
-5,100
| -0.5% | -$209K |
|
875
VF Corp
VFC
$5.79B
| $48.6M | 0.01% |
819,843
+58,520
| +8% | +$3.4M |
|
Similar funds
T. Rowe Price Associates's Q2 2014 Portfolio in Review
As of Q2 2014, T. Rowe Price Associates held 2,596 positions worth $463B, up 3.9% from $445B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
T. Rowe Price Associates's Q2 2014 filing shows 97 new, 1,091 increased, 793 reduced and 67 closed positions. Its largest new stake was Teva Pharmaceuticals: 4,638,481 shares worth $243M. The largest sale was Procter & Gamble, an estimated $1.4B.
By sector, the portfolio is most concentrated in Healthcare at 17% of assets, up from 16% a quarter earlier, followed by Consumer Discretionary and Financials.
- T. Rowe Price Associates's largest Q2 2014 buy was Teva Pharmaceuticals: 4,638,481 shares worth $243M.
- T. Rowe Price Associates added most to Allergan Inc in Q2 2014, an estimated $1.3B increase.
- T. Rowe Price Associates's biggest Q2 2014 reduction was Procter & Gamble, cutting an estimated $1.4B.
- T. Rowe Price Associates fully exited Santander in Q2 2014, selling an estimated $134M.
- T. Rowe Price Associates's ten largest holdings make up 12% of its $463B portfolio in Q2 2014.
- T. Rowe Price Associates opened 97 new positions and closed 67 in Q2 2014.
- T. Rowe Price Associates's portfolio value rose 3.9% quarter-over-quarter to $463B.
Based on T. Rowe Price Associates's 13F filing for Q2 2014, filed 14 Aug 2014.